Navigation Links
MedQuist Launches BenchMark KB(R) Knowledge Base
Date:4/28/2010

rkforce development and credentialing in allied health and the critical role of the technology-enabled documentation knowledge worker in the electronic health record (EHR).

About MedQuist

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions – including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors – help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

MedQuist offers an industry-leading healthcare information management platform (DocQment Enterprise Platform®), which serves as the foundation for its transcription service offerings and includes workflow management, core measures reporting, structured documentation, data analytics, and key customer reporting.  In addition, MedQuist solutions include SpeechQ™ real-time interactive speech recognition for radiology and general medicine, DocQvoice™ for capturing dictation, and computer-assisted coding and abstracting.  This blend of solutions drives document quality and accuracy and advances the adoption of electronic health records -- resulting in improved patient care and higher levels of efficiency.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are
'/>"/>

SOURCE MedQuist Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. MedQuist Performance Monitor Offers Transparency, Detailed Reporting and Measurement of Clinical Documentation Metrics
2. MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology
3. MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties
4. MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention
5. MedQuist Announces Reseller Agreement With Clario
6. Actavis Launches Generic Version of Flomax(R) In The U.S.
7. The Vanishing Oath, the First Physician-Focused Documentary on the Dangers of the American Healthcare System, Launches on DVD May 5
8. NeoStem, Inc. Officially Launches Adult Stem Cell Collection Center and R&D Laboratory in Cambridge, Massachusetts
9. FDA Launches Initiative to Reduce Infusion Pump Risks
10. Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
11. EndoChoice(R) Launches CEU Program on Proper Endoscope Reprocessing and a Line of Flexible Endoscope Reprocessing Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 Inovio ... successful results from its randomized, double-blind, placebo-controlled ... with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) ... or 18. Treatment with VGX-3100, Inovio,s HPV16/18-specific ... to CIN1 or no disease, meeting the ...
(Date:7/23/2014)...  The management team at Columbia Laboratories, Inc. ... conference call on July 31, 2014, to discuss ... 30, 2014.  The call details are as follows:Date: ... EDTDial-in numbers: , Toll free: (877) 870-4263 (U.S.), ... archive): , www.columbialabs.com , under ,Investor, or ...
(Date:7/23/2014)... Global healthcare company GSK reports ... headwinds, increased price competition and supply disruptions to its ... points out that the company is very much in ... be confident about long-term prospects as well as the ... CFO Simon Dingemans adds that the company ...
Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
... SPRING, Md., June 20, 2011 The U.S. Food ... help advance the development and approval of an artificial ... United States. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... condition in which the pancreas produces little or no ...
... (NYSE Amex: CUR ) announced that it has ... Phase Ia trial to test the safety of NSI-189 for ... drug in healthy volunteers for safety and tolerability. NSI-189 is ... new neuron growth in the hippocampus, an area of the ...
Cached Medicine Technology:FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 2FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 3Neuralstem Updates NSI-189 Major Depression Trial 2Neuralstem Updates NSI-189 Major Depression Trial 3
(Date:7/23/2014)... on human cancer genes have been focused on the ... be translated in the form of amino acids thus ... regulatory region or activator which controls the expression and ... was known of the role exerted such DNA fragment ... in Nature in collaboration with the group ...
(Date:7/23/2014)... Irvine, Calif., July 23, 2014 A therapy combining ... of a gene inhibitor into the brain restored voluntary ... UC Irvine,s Reeve-Irvine Research Center have found. , In ... achieved this breakthrough by turning back the developmental clock ... corticospinal tract nerve connections and providing a scaffold so ...
(Date:7/23/2014)... This report defines and segments the ... the Middle East & Africa, and Americas) - Global ... with analysis and forecasts of the global revenue. The ... over $10 billion in 2014 to nearly $14 billion ... , browse 49 Market Tables and 10 Figures Spread ...
(Date:7/23/2014)... A Forever Recovery, an open-ended drug and ... great start and gives them a solid foundation in ... Internet Addiction section of its website at http://aforeverrecovery.com/behavioral-addictions/internet-addiction/ ... Internet addiction is not just as legitimate a disorder ... trapping more and more victims each year – particularly ...
(Date:7/23/2014)... Children and teens who lose a parent might face an ... study suggests. People who were children or teens when ... death during the study period than those who had not ... Although the study found an association between a parent,s ... wasn,t designed to prove cause-and-effect. Also, the increased risk ...
Breaking Medicine News(10 mins):Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2
... significantly slow or halt science's ability to establish ... by industry, a team of scientists and lawyers ... caution that litigation's effects could seriously impair efforts ... variety of diseases, including Parkinson's disease, Alzheimer's disease ...
... blood flow to the brain, helps the bodies detoxify ... Alzheimer's, say researchers. ,"Exercise improves thinking and mental ... associate professor of medicine at the New York University ... Health Central. ,"Studies have shown that it works ...
... and PRK eye procedures are safe and effective, according ... recent American Academy of Ophthalmology’s //Joint Meeting. ,Researchers ... PRK treatments say both procedures provide stable, long term ... answer to those who doubt LASIK’s reliability, showing that ...
... big, juicy steak for dinner last night, adding a large amount ... For one in ten of us, that could be a big ... our diet, our bodies use it for energy. But patients with ... of Americans – are more likely to develop arthrosclerosis, or build-up ...
... the age when reading a newspaper means holding ... glasses, wavefront-optimized //lens technology may offer a better ... American Academy of Ophthalmology’s 2006 Joint Meeting. ... lenses developed using wavefront technology offer significant improvements ...
... Blaming the resurfacing of polio cases in the Indian ... //Delhi Chief Minister Sheila Dikshit Saturday said that around ... part of the Pulse Polio programme. ,"Delhi was ... occurrence of fresh cases, mostly due to migration of ...
Cached Medicine News:Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 2Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 3Health News:PRK and LASIK Surgeries ‘Safe and Effective 2Health News:Sugars in Liver Found to Clear Fats from the Bloodstream 2Health News:Beyond Bifocals: Wavefront Technology Benefits Patients With Presbyopia 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: